Albany, New York, August 16, 2017: Human papilloma virus (HPV) is a form of the virus which can cause cervix cell changes. Hence, the HPV test is important for the diagnosis of issues such as cervical cancer. To study briefly about the HPV testing market, a fresh report has been added to the wide online collection managed by Market Research Reports Search Engine (MRRSE). The report titled “Human Papillomavirus (HPV) Testing Market: Global Industry Analysis 2012–2016 and Forecast 2017 – 2025”, offers exact details related to the current market status along with regional divergence all across the globe. Also, the report includes market analysis and forecast for the period between 2017 and 2025. As per research study findings, the market is expected to acquire a value of US$ 1,130 Mn by the end of 2025, portraying a CAGR of 7.6% over the stated forecast period.
HPV viruses are generally termed as papilloma viruses due to their tendencies to cause papilloma or warts. It is important to know that, few HPVs are even cancer causing viruses. Further, HPVs can be grouped as low-risk genital HPV types and high-risk genital HPV types. To understand in-depth, the research study is divided into four distinct sections. The initial portion talks about the market overview, PMR analysis, and market taxonomy. These aspects are necessary to make the readers familiar with the human papilloma virus testing market. This section also encloses the market opportunity analysis, which includes information about macro-economic factors.
The following section offers a geographical segmentation considered various factors such as key regulations, market dynamic (drivers, restraints, and trends) and historical market size, 2012-2016. The prime market regions are North America, Europe, Latin America, Asia Pacific and Middle East & Africa. Readers also get to acquire knowledge about the papillomavirus (HPV) testing market analysis and forecast together with important market metrics such as year-on-year growth rates, BPS analysis, absolute dollar opportunity, and market attractiveness analysis. The report presents a market segmentation based on product type, namely, DNA-based test and RNA-based test. Presently, the end-user for HPV testing include hospitals, diagnosis centers, clinics and research institutes.
The final section of the report is dedicated for the competitive landscape of the HPV testing market. Each of the leading companies is also profiled individually along with important information about the company such as company description, company details, and product portfolio. Also, key developments and strategic analysis are also available in this section.